Login to Your Account

Evotec banks $45M in Celgene CNS drug discovery pact

By Cormac Sheridan
Staff Writer

Friday, December 16, 2016

DUBLIN – Evotec AG is banking $45 million up front and stands to earn up to $250 million more in per-program milestones from a drug discovery pact in neurodegenerative disease with Celgene Corp.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription